1. |
Heller MT, Shah AT. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am, 2011, 49(3):529-548.
|
2. |
Eriksson B, Oberg K. Neuroendocrine tumors of the pancreas[J]. Br J Surg, 2000, 87(2):129-131.
|
3. |
Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification[J]. Ann NY Acad Sci, 2004, 1014(1):13-27.
|
4. |
Kulke MH, Anthony LB, Bushe11 DL, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas[J]. Pancreas, 2010, 39(6):735-752.
|
5. |
Yao JC, Hassan M, Phan A, et al. One hundred years after“carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35 825 cases in the United States[J]. J Clin Oncol, 2008, 26(18):3063-3072.
|
6. |
Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin N Am, 2011, 40(1): 1-18.
|
7. |
Jensen RT, Niederle B, Mitry E, et al. Gastrinoma (duodenal and pancreatic)[J]. Neuroendocrinology, 2006, 84(1):173-182.
|
8. |
Kloppel G, Anlauf M. Gartrinoma-morphological aspects[J]. Wein Klin Wocherschr, 2007, 119(5):574-584.
|
9. |
Vanderveen K, Grant C. Insulinoma[J]. Cancer Treat Res, 2010, 153(2):235-252.
|
10. |
Jensen RT, Cadiot G, Brandi ML. ENETs consensus guidelines for the management of patients with digestive neuroendocrineneoplasms:functional pancreatic endocrine tumor syndromes[J]. Neuroendocrinology, 2012, 95(1):98-119.
|
11. |
Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology[J]. Arch Pathol Lab Med, 2008, 132(8):1285-1289.
|
12. |
Bosman FT. WHO Classification of Tumors of the DigestiveSystem[M]. Lyon , IARC Press, 2010.
|
13. |
De Herder WW, Niederle B, Scoazes JY, et al. Well-differentiated pancreatic tumor/carcinoma:insulinoma[J]. Neuroendoocrinology, 2006, 84(1):183-188.
|
14. |
Vinik AI, Gonzales MRC. New and emerging syndromes due to neuroendocrine tumors[J]. Endocrinol Metab Clin N Am, 2011, 40(1):19-63.
|
15. |
Osefo N, Ito T, Jensen RT. Gastric acid hypersecetory states:recent insights and advances[J]. Curr Gastroenterol Rep, 2009, 11(4):433-441.
|
16. |
Metz DG, Jensen RT. Gastrointestinal neuroendocrine tumors:pancreatic endocrine tumors[J]. Gastroenterology, 2008, 135(5):1469-1492.
|
17. |
Heller MT, Shah AB. Imaging of neuroendocrine tumors[J]. Radiol Clin N Am, 2011, 49(3):529-548.
|
18. |
Morrow EH, Norton JA. Surgical management of Zollinger-Ellison syndrome; state of the art[J]. Surg Clin North Am, 2009, 89(5):1091-1103.
|
19. |
Ruf J, Heuck F, Schiefer J, et al. Impact of multiple 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors[J]. Neuendocrinology, 2010, 91(1):101-109.
|
20. |
Sundin A, Garake U, Orlefors H. Nuclear imaging of neurooendocrine tumors[J]. Best Pract Res Clin Endocrinal Metab, 2007, 21(1):69-85.
|
21. |
Norton JA, Jeusen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellisonsyndrome[J]. Ann Surg , 2004, 240(5):757-773.
|
22. |
Gouolet P, Muret A, Bingut C, et al. Risk factors and causes of death in MEN-1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients[J]. World J Surg, 2010, 34(2):249-255.
|
23. |
Figueiredo FA, Giovannini M, Monges G, et al. Pancreaticendocrine tumors:a large single center experience[J]. Pancrease, 2009, 38(8):936-940.
|
24. |
Boudrcause JP. Surgery for gastroenteropancreatic neuroendocrine tumors[J]. Endocrinol Metab Clin North Am, 2011, 40(1):163-171.
|
25. |
Woltering E, Cundiff, Lyous J. Neuroendocrine tumors of the gastroenteropancreatic axis//Silberman H, Silberman AW. ed. Principles and Practice of Surgical Oncology[M]. Philadephia:Lippincott Williams & Wilkins, 2010:769-800.
|
26. |
Lorenz K, Dralle H. Surgical treatment of sporadic gastrinoma[J]. Wien Klin Wochenschr, 2007, 119(19-20):597-601.
|
27. |
Grobmyer SR, Vogel SB, McGuigan JE, et al. Reoperativesurgery in sporadic Zollinger-Ellison Syndrome:long-term results[J]. J Am Coll Surg, 2009, 208(6):718-722.
|
28. |
Fendrich V, Langer P, Waldmann J, et al. Management ofsporadic and multiple endocrine neoplasia type 1 gastrinomas[J]. Br J Surg, 2007, 94(11):1331-1341.
|
29. |
Fernandaz-Cruz L, Blanco L, Cosa R, et al. Is laparoscopic resection adequate in patients with neoroendocrine pancreatictumors[J]. World J Surg, 2008, 32(5):904-917.
|
30. |
Isla A, Arbuckle JD, Kekis PB, et al. Laparoscopic management of insulinoma[J]. Br J Srug, 2009, 96(2):185-190.
|
31. |
Gimm V, König E, Thanh PN, et al. Intraoperative quick insulin assay to confirm complete resection of insulinomas guided by selective arterial calcium injection (SACI)[J]. Langenbecks Arch Surg, 2007, 392(6):679-684.
|
32. |
Akerstron G, Hellman P. Surgery on neuroendocrine tumors[J]. Best Pract Res Clin Endocrinol Metab, 2007, 21(1):87-109.
|
33. |
Joseph S, Wang YZ, Boudreaux JP, et al. Neuroendocrinetumors: current recommendations for diagnosis and surgical management[J]. Endocrinol Metab Clin North Am, 2011, 40(1):205-231.
|